Clinical trial / 1999
Olestra increased fecal excretion of TCDD by eight- to tenfold in two patients with chloracne.
Two patients with chloracne had 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) levels of 144,000 and 26,000 pg/g blood lipids. Ingestion of olestra, a non-digestible lipophilic dietary fat substitute, accelerated intestinal excretion of TCDD by eight- to tenfold. This rate of increase is sufficient to decrease the normally observed TCDD elimination half-life from approximately 7 years to 1-2 years.
- Study type
- Case report / intervention
- Who was studied
- Two patients with chloracne and high blood lipid concentrations of TCDD
- What was measured
- Intestinal/faecal excretion and estimated elimination half-life of TCDD
THE PAPER
Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Geusau A, Tschachler E, Meixner M, Sandermann S, Päpke O, Wolf C, Valic E, Stingl G, McLachlan M. Lancet, 1999.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.